NUWE vs. SSKN, QTI, STRR, GIA, NXL, HSDT, NDRA, TIVC, VIVE, and VRAYQ
Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include STRATA Skin Sciences (SSKN), QT Imaging (QTI), Star Equity (STRR), GigCapital5 (GIA), Nexalin Technology (NXL), Helius Medical Technologies (HSDT), ENDRA Life Sciences (NDRA), Tivic Health Systems (TIVC), Viveve Medical (VIVE), and ViewRay (VRAYQ).
STRATA Skin Sciences (NASDAQ:SSKN) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, community ranking, risk, earnings, profitability, media sentiment and valuation.
STRATA Skin Sciences has a beta of 1.53, indicating that its share price is 53% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.31, indicating that its share price is 69% less volatile than the S&P 500.
STRATA Skin Sciences has higher revenue and earnings than Nuwellis. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.
In the previous week, Nuwellis had 1 more articles in the media than STRATA Skin Sciences. MarketBeat recorded 3 mentions for Nuwellis and 2 mentions for STRATA Skin Sciences. STRATA Skin Sciences' average media sentiment score of 0.72 beat Nuwellis' score of 0.29 indicating that Nuwellis is being referred to more favorably in the news media.
STRATA Skin Sciences received 204 more outperform votes than Nuwellis when rated by MarketBeat users. Likewise, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 50.00% of users gave Nuwellis an outperform vote.
STRATA Skin Sciences has a net margin of -34.92% compared to STRATA Skin Sciences' net margin of -202.97%. Nuwellis' return on equity of -65.76% beat STRATA Skin Sciences' return on equity.
32.4% of STRATA Skin Sciences shares are held by institutional investors. Comparatively, 3.1% of Nuwellis shares are held by institutional investors. 40.4% of STRATA Skin Sciences shares are held by insiders. Comparatively, 2.6% of Nuwellis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
STRATA Skin Sciences presently has a consensus price target of $3.80, indicating a potential upside of 923.16%. Given Nuwellis' higher possible upside, research analysts clearly believe STRATA Skin Sciences is more favorable than Nuwellis.
Summary
STRATA Skin Sciences beats Nuwellis on 12 of the 16 factors compared between the two stocks.
Get Nuwellis News Delivered to You Automatically
Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NUWE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuwellis Competitors List
Related Companies and Tools
